Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Офтальмология / Английские материалы / Essentials in Ophthalmology Oculoplastics and Orbit Aesthetic and Functional Oculofacial Plastic Problem-Solving in the 21st Century_Guthoff, Katowitz_2009.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
31.42 Mб
Скачать

Chapter 6

 

Clinicopathologic Features of Lesions

 

A ecting the Lacrimal Drainage System

6

in External Dacryocystorhinostomy

Ludwig M. Heindl, Anselm G. M. Jünemann, and Leonard M. Holbach

Core Messages

Differential diagnostic symptoms and signs in favor of a tumor of the lacrimal sac include a swelling above the medial canthal tendon, the presence of telangiectases in the skin overlying the mass, and the presence of serosanguinous discharge or a bloody reflux with atraumatic irrigation.

All patients should be asked for a history of predisposing conditions, such as systemic diseases (e.g., lymphoma, Wegener granulomatosis, sarcoidosis) or neoplasms.

External dacryocystorhinostomy (DCR) allows detailed inspection of the lacrimal sac and adequate tissue biopsy.

Lacrimal sac biopsy should be considered selectively in patients with atypical clinical or intraoperative findings or in those with a history of predisposing systemic diseases.

Biopsy results may help to define the degree of active specific inflammation requiring further chemoor immunotherapy postoperatively.

Selective lacrimal sac biopsy permits early diagnosis of potentially life-threatening malignant tumors to determine further definitive management.

6.1 Introduction

 

loma, mixed-cell papilloma, oncocytoma) and malignant

 

(squamous cell carcinoma, transitional cell carcinoma,

 

 

Disorders of the lacrimal drainage system (Table 6.1),

adenocarcinoma, mucoepidermoid carcinoma, oncocytic

which cause epiphora, punctal discharge, or medial can-

adenocarcinoma) tumors [6, 9, 10, 17–19]. Mesenchymal

thal swelling, are common ophthalmic complaints com-

tumors such as fibrous histiocytoma, fibroma, heman-

prising approximately 3% of clinic visits in some series

gioma, hemangiopericytoma, angiosarcoma, or lipoma

[8, 21]. The most common histopathologic findings in

are less common (14%), and the rarer tumors include

primary acquired nasolacrimal duct obstruction include

lymphomas (8%), malignant melanomas (4%), and neu-

chronic inflammation and fibrosis leading to occlusion

ral tumors (1%) (Table 6.2) [6, 9, 10, 17–19]. Secondary

of the lacrimal drainage system [7, 12, 13]. Secondary

tumors originating in adjacent structures (paranasal

causes of dacryostenosis may be the result of neoplasms,

sinuses, orbit, nose) may extend into the lacrimal sac [6,

systemic inflammatory diseases, infections, or trauma

9, 10, 17–19]. Metastatic neoplasms confined to the lacri-

[2, 19].

 

mal sac are extremely rare, and most metastases also

Neoplasms that affect the lacrimal drainage system are

affect adjacent structures, such as the eyelid, nose, sinuses,

rare, but potentially life-threatening, so early diagnosis

and orbit [6, 9, 10, 17–19].

and treatment are particularly important [17, 23]. Almost

Inflammatory lesions, including nonspecific chronic

500 primary lacrimal sac tumors have been reported and

inflammation (“pseudotumor”) or granulomatous dis-

were malignant in about 55% of the cases [6, 9, 10, 17–19].

ease, are not true neoplasms but may present as lacrimal

Epithelial neoplasms are most common (73%), including

sac masses and may be a sign of systemic diseases that

benign (squamous cell papilloma, transitional cell papil-

require further medical treatment [6, 17–19].

96

6 Clinicopathologic Features of Lesions A ecting the Lacrimal Drainage System

Table 6.1. Differential diagnosis of lacrimal drainage disorders

Punctal causes of epiphora

– Congenital punctal atresia

6– Punctal ectropion in eyelid malposition

Acquired punctal stenosis due to age-related atrophic processes, chronic inflammation, cicatricial conjunctival disease, systemic chemotherapeutic agents

Canalicular causes of epiphora

Congenital absence or fistula

Acquired intrinsic disorders: postherpetic infection (herpes simplex, varicella zoster); bacterial infection (e.g., Actinomyces, Chlamydia); trauma; postirradiation; pharmacological; intrinsic tumor (e.g., squamous papilloma, squamous cell carcinoma)

Acquired extrinsic disorders: compression or invasion and occlusion by adjacent tumor (e.g., basal cell carcinoma, squamous cell carcinoma, non-Hodgkin B-cell lymphoma)

Lacrimal sac causes of epiphora

Congenital diverticulum or fistula (from sac to nose or cheek)

Acquired intrinsic disorders: inflammation (extension of primary acquired nasolacrimal duct obstruction, including dacryoliths, Wegener granulomatosis, sarcoidosis, allergy, hay fever, atopy), trauma, intrinsic tumor arising within the sac or the sac walls (Table 6.2)

Acquired extrinsic disorders: adjacent tumor compressing or invading the sac from the outside (e.g., basal cell carcinoma, squamous cell carcinoma, non-Hodgkin B-cell lymphoma, neurofibroma)

Nasolacrimal duct causes of epiphora

Congenital nasolacrimal duct obstruction (delayed opening of valve of Hasner with or without dacryocele, craniofacial abnormality, rare nasolacrimal duct agenesis)

Primary acquired nasolacrimal duct obstruction (most common cause in adults)

Secondary acquired lacrimal obstruction, including trauma and tumors (as for sac and those extending from the maxillary sinus) Nasal causes of epiphora

Allergic rhinitis, severe rhinosinus disease (e.g., polyps), previous nasal surgery

Tumors spreading from nasal space or adjacent sinuses

Source: Adapted from [8]

Table 6.2. Lacrimal sac tumors

I.Epithelial tumors

1.Squamous cell papilloma

2.Transitional cell papilloma

3.Mixed-cell papilloma (exophytic or endophytic)

4.Oncocytic adenoma (oncocytoma)

5.Squamous cell carcinoma

6.Transitional cell carcinoma

7.Adenocarcinoma

8.Mucoepidermoid carcinoma

9.Oncocytic adenocarcinoma

II.Nonepithelial tumors

1.Fibrous histiocytoma

2.Pyogenic granuloma

3.Neurilemmoma

4.Lymphoid tumors

5.Malignant melanoma

6.Angiosarcoma

Source: Modified from [6]

The recognition and proper management of such lifethreatening lesions require an understanding of the anatomy and general diagnostic techniques of the lacrimal drainage system.

6.2Surgical Anatomy of the Lacrimal Drainage System

On lid closure, tears are wiped to the nasal bulbar conjunctiva and tear meniscus and are then drained through the superior and inferior lacrimal puncta, which are open only with open eyes, and canaliculi into the lacrimal sac and by a sort of “lacrimal peristalsis” into the nose (Fig. 6.1). The canaliculi start with a 2-mm vertical component and continue with a horizontal portion 8–10 mm long. The common canaliculus, 1–2 mm long, leads into the lacrimal sac. Its entry into the sac at the internal ostium is often partially covered by a mucosal flap, which is based anteriorly and also called “the valve of

6.4 Selective Lacrimal Sac Biopsy in External Dacryocystorhinostomy

97

Fig. 6.1 Schematic illustration of the lacrimal drainage system with approximate measurements (Redrawn from [8])

Rosenmüller.” The lacrimal sac lies in the fossa between the anterior (frontal process of maxilla) and posterior (lacrimal bone) lacrimal crest and is surrounded by the anterior and posterior limbs of the medial canthal tendon. The body of the sac measures 10–12 mm in vertical height, and 3–5 mm of the sac (fundus) lie above the internal ostium. The suture line in the lacrimal fossa runs vertically between the thin lacrimal bone and the thicker frontal process of the maxilla. It is mostly located one half of the way from the anterior to the posterior lacrimal crest. The sac leads into the bony nasolacrimal duct, which measures 12–15 mm in length and travels within the wall of the maxillary sinus and the lateral nasal wall. The duct extends for about 5 mm below the bony portion and opens beneath the inferior turbinate in the lateral wall of the nose. A mucosal valve (Hasner) usually prevents retrograde passage of mucus or air upward. The nasal entry site of a DCR lies at the anterior tip of the middle turbinate. The ethmoid sinus may extend to the lacrimal sac fossa. Bony removal of the lacrimal sac fossa may result in entry into the ethmoid sinus rather than into the nasal vault [8, 20].

6.3Basic Diagnostics for Disorders of the Lacrimal Drainage System

Prior to clinical examination, it is helpful to ask the patient for severity, duration, and quality of symptoms. The most common symptoms indicating dysfunction of the lacrimal drainage system include epiphora, punctal discharge, and medial canthal swelling. Epiphora is

typically worse in the winter months and windy weather. The eye can be sticky due to an expressible mucocele or collected dried tears. The vision can be blurred secondary to an elevated tear meniscus (prismatic effect, especially on downgaze, for example, when reading) or tear-splat- tered glasses. Chronic epiphora can induce red, sore lower lid skin, with secondary anterior lamella (vertical) shortening (mild cicatricial ectropion). Excessive wiping away of tears can cause or exacerbate a medial ectropion.

Mucopurulent punctal discharge suggests stasis in the lacrimal sac or canaliculi, mostly secondary to nasolacrimal duct obstruction. Accumulation of inflammatory debris can result in dacryolithiasis in up to 15% of DCR surgeries. Lacrimal sac stones consist of dried mucus, lipid, and inflammatory cells and are more likely to be found in chronically inflamed sacs.

Medial canthal swelling may be caused by an abscess, a dacryolith, or a tumor in the lacrimal sac. But, not all masses in the medial canthal area arise from the lacrimal sac (acute skin infection, acute ethmoiditis, ruptured dermoid cyst). Swellings below the medial canthal tendon are typical of dacryocystitis. Differential diagnostic signs in favor of a tumor of the lacrimal sac include a mass above the medial canthal ligament (absent in dacryocystitis), the presence of telangiectases in the skin overlying the mass (instead of the diffuse erythema of dacryocystitis) and the presence of serosanguinous discharge or a bloody reflux with atraumatic irrigation (both of which are not usually observed in dacryocystitis).

All patients should be asked not only for their complaints, but also for the history of predisposing conditions, such as systemic diseases (e.g., lymphoma, Wegener granulomatosis, sarcoidosis), trauma, neoplasms, and dacryocystitis.

In addition to a comprehensive ophthalmic examination, particularly with regard to ocular surface disease and eyelid and punctum position, the assessment of the lacrimal drainage system must include inspection, palpation, digital expression of lacrimal sac contents, and standard irrigation and probing of the nasolacrimal system. Imaging studies (dacryocystography, computed tomography (CT), magnetic resonance imaging) are reserved for selected patients with atypical symptoms and signs. Detailed history taking and nasal endoscopy must be performed by an otorhinolaryngologist to rule out intranasal pathology [8].

6.4Selective Lacrimal Sac Biopsy in External Dacryocystorhinostomy

Although endonasal endoscopic DCR is gaining clinical popularity in the therapy of acquired dacryostenosis, the external DCR is regarded as the gold standard in terms of

 

 

98

6 Clinicopathologic Features of Lesions A ecting the Lacrimal Drainage System

 

 

surgical success [4, 5, 14, 16]. In addition, the external

of patients with and without lacrimal sac biopsy during

 

 

approach allows an excellent possibility for inspection of

external DCR. In our series of 421 consecutive patients

 

 

the lacrimal sac (Fig. 6.2) and for biopsy (excisional

undergoing external DCR with selective lacrimal sac

 

or incisional

with debulking) of abnormal-appearing

biopsy, no significant difference was detectable

6

findings.

 

between patients with and without biopsy regarding

 

 

In view of lacrimal tumors mimicking symptoms and

5-year overall survival. None of the patients without

 

 

 

 

signs of primary acquired nasolacrimal duct obstruction,

biopsy developed clinical evidence of systemic inflam-

 

 

some lacrimal surgeons perform “routine” lacrimal sac

matory diseases (e.g., Wegener granulomatosis, sarcoi-

 

 

biopsy during external or endonasal DCR [1, 3, 11–13,

dosis) or neoplasms of the lacrimal drainage system

 

 

15, 22]. Incidence rates for significant lacrimal sac pathol-

within follow-up.

 

 

ogies that require further medical or surgical interven-

Our follow-up results are compatible with the findings

 

 

tion varied between 0% and 14% of biopsy specimens

of seven previously published series with routine lacrimal

 

 

obtained routinely during DCR [1, 3, 11–13, 15, 22].

sac biopsy [1, 3, 11–13, 15, 22]. Here, only 7 of 1,294 speci-

 

 

Since recent clinicopathologic studies revealed signifi-

mens (0.5%) showed specific pathology that was definitely

 

cant histopathologic findings only in clinically suspicious

not suspected clinically, and only 1 of these (0.08%) was

 

cases [3, 11, 15], we suggest selective lacrimal sac biopsy

found to be malignant (lymphoma) [1, 3, 11–13, 15, 22].

 

during external DCR only for patients with atypical clini-

Using selective lacrimal sac biopsy only in patients

 

cal or intraoperative findings rather than routine biopsy

with atypical clinical or intraoperative findings, positive

 

of all patients with primary acquired nasolacrimal duct

biopsy results could be found in 3.8% of 442 consecutive

 

obstruction.

 

external DCR procedures: primary non-Hodgkin B-cell

 

 

If lacrimal sac biopsy is not performed in all cases of

lymphoma (mucosa-associated lymphoid tissue, MALT)

 

primary acquired nasolacrimal duct obstruction, the

in one patient, secondary bilateral non-Hodgkin B-cell

 

risk of overlooking significant pathologies that require

lymphoma (MALT) in one patient, squamous cell carci-

 

further medical or surgical intervention should be kept in

noma in two patients, malignant melanoma in one

 

mind. Therefore, we compared the long-term follow-up

patient, oncocytoma in one patient, pyogenic granuloma

 

 

 

 

in three patients, Wegener granulomatosis in three

 

 

 

 

patients (one bilateral), and sarcoidosis in two patients

 

 

 

 

(one bilateral) (Table 6.3).

 

 

 

 

Our results are compatible with the pooled data of

 

 

 

 

seven previously published series with routine lacrimal

sac biopsy [1, 3, 11–13, 15, 22] revealing significant pathology in 50 of 1,294 specimens (3.9%). In detail, significant lacrimal sac pathology was detected in 2 of 14 specimens (14.3%) in Linberg and McCormick’s series (one sarcoidosis, one leukemia) [12]; in 4 of 162 specimens (2.5%) in Tucker et al.’s series (two lymphoma, one sarcoidosis, one oncocytoma) [22]; in 10 of 302 specimens (3.3%) in Bernardini et al.’s series (four sarcoidosis,

Fig. 6.2 External DCR allows an excellent possibility for inspection of the lacrimal sac and for taking biopsy samples of abnormal-appearing findings

Table 6.3. Results of selective lacrimal sac biopsies

Histopathology

No. of cases (% total)

Non-Hodgkin B-cell lymphoma

3

(18%)

(MALT)

 

 

Squamous cell carcinoma

2

(12%)

Malignant melanoma

1

(6%)

Oncocytoma

1

(6%)

Pyogenic granuloma

3

(18%)

Wegener granulomatosis

4

(24%)

Sarcoidosis

3

(18%)